FDA and CDC greenlight Pfizer COVID-19 vaccine for children ages 5 to 11
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11. Coupled with the Food and Drug Administration’s Oct. 29 emergency use authorization to Pfizer for its pediatric Covid-19 vaccine, this recommendation paves the way for the product’s administration to this age group immediately.
Related News Articles
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…
Headline
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review…
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…
#HealthCareInnovation Blog
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
The Department of Health and Human Services has partnered with Baby2Baby to distribute 3,000 newborn supply kits to new mothers through participating hospitals…
Headline
The Health Resources and Services Administration announced a new toll-free number (1-833-TLC-MAMA) and promotional toolkit for its National Maternal…